AJO LP’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-75,062
| Closed | -$4.46M | – | 487 |
|
|
2020
Q3 | $4.46M | Buy |
+75,062
| New | +$4.46M | 0.05% | 276 |
|
|
2020
Q1 | – | Sell |
-2,568
| Closed | -$167K | – | 706 |
|
|
2019
Q4 | $167K | Sell |
2,568
-309,605
| -99% | -$20.1M | ﹤0.01% | 518 |
|
|
2019
Q3 | $19.4M | Buy |
312,173
+2,671
| +0.9% | +$166K | 0.11% | 168 |
|
|
2019
Q2 | $22M | Sell |
309,502
-36,866
| -11% | -$2.63M | 0.11% | 172 |
|
|
2019
Q1 | $27.2M | Sell |
346,368
-71,938
| -17% | -$5.64M | 0.14% | 166 |
|
|
2018
Q4 | $35.4M | Sell |
418,306
-5,046
| -1% | -$427K | 0.2% | 129 |
|
|
2018
Q3 | $72.5M | Sell |
423,352
-61,283
| -13% | -$10.5M | 0.34% | 93 |
|
|
2018
Q2 | $62.6M | Sell |
484,635
-23,029
| -5% | -$2.98M | 0.29% | 108 |
|
|
2018
Q1 | $52.3M | Buy |
507,664
+322,580
| +174% | +$33.2M | 0.24% | 116 |
|
|
2017
Q4 | $15.8M | Buy |
185,084
+123,960
| +203% | +$10.6M | 0.07% | 197 |
|
|
2017
Q3 | $5.19M | Buy |
61,124
+50,119
| +455% | +$4.26M | 0.02% | 312 |
|
|
2017
Q2 | $833K | Sell |
11,005
-138,502
| -93% | -$10.5M | ﹤0.01% | 503 |
|
|
2017
Q1 | $9.87M | Buy |
149,507
+69,434
| +87% | +$4.58M | 0.04% | 213 |
|
|
2016
Q4 | $5.08M | Sell |
80,073
-116,080
| -59% | -$7.36M | 0.02% | 271 |
|
|
2016
Q3 | $12.5M | Sell |
196,153
-471,570
| -71% | -$30M | 0.05% | 206 |
|
|
2016
Q2 | $49.7M | Sell |
667,723
-293,780
| -31% | -$21.9M | 0.22% | 109 |
|
|
2016
Q1 | $64.2M | Buy |
961,503
+659,187
| +218% | +$44M | 0.28% | 100 |
|
|
2015
Q4 | $20.4M | Buy |
302,316
+236,487
| +359% | +$16M | 0.09% | 173 |
|
|
2015
Q3 | $3.52M | Buy |
65,829
+11,022
| +20% | +$589K | 0.02% | 319 |
|
|
2015
Q2 | $3.45M | Buy |
+54,807
| New | +$3.45M | 0.01% | 341 |
|